Research Awards Banner.png

Jump to... 

Contact us...

  • Email LSO@vanderbilt.edu if you are interested in an opportunity not listed below or have questions regarding the LSO submission process.

 


Active Internal Calls for Limited Submission Nominations 

Internal review process required to choose institutional nominees


Limited Submission Eligibility Guidelines

The following tags serve as a guide for submission instructions.

Vanderbilt (VU + VUMC)

  • VU and VUMC submit collaboratively to this LSO. ALL investigators should follow the guidelines posted on this site.

VUMC

  • VU and VUMC submit separately to this LSO. VUMC investigators should follow the guidelines posted on this site. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

FEATURED OPPORTUNITY

  • High-profile or prestigious awards of particular interest to Vanderbilt investigators

Brain Research Foundation’s 2020 Scientific Innovations Award

Applications due April 26

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions

Overview:

Vanderbilt (VU + VUMC, collaboratively) may nominate one senior faculty member to submit a Letter of Intent for Brain Research Foundation’s 2020 Scientific Innovations Award (SIA). The SIA program provides $150,000 over two years for innovative science in both basic and clinical neuroscience. This funding mechanism is designed to support creative, exploratory, cutting edge research in well-established research laboratories, under the direction of established investigators.

The SIA supports projects that may be too innovative and speculative for traditional funding sources but still have a high likelihood of producing important findings. It is expected that investigations supported by these grants will yield high impact findings and result in major grant applications and significant publications in high impact journals. Please note that indirect costs are prohibited.

Eligibility:

  • Nominee must be a full-time associate professor or full professor working in the area of studies of brain function in health and disease. Research associate professors are ineligible.
  • Current major NIH or other peer-reviewed funding is preferred. Evidence of such funding in the past three years is essential.
  • Studies should be related to either normal human brain development or specifically identified disease states. This includes molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease.
  • The grant proposal must detail a new research project that is not funded by other sources. This grant is not to be used as bridge funding.
  • PI is ineligible if they have BRF funding that will overlap this grant period. Scientists that have previously received a BRF Scientific Innovations Award may not receive the award for a second time until five years has elapsed since the beginning date of the prior award.
  • Collaboration is allowed but the application may only list a single PI.

Internal Application Process:

Anyone interested in being considered as Vanderbilt’s nominee must submit the following (in PDF format) to LSO@vanderbilt.edu by 5 p.m. on April 26, 2019: 

  1. Brief summary of program project/research plan (2 page maximum). Please include a closing paragraph that explains how this research will develop (next steps) 
  2. Statement of support from department chair/center director
  3. NIH Biosketch (5 page maximum; should include list of support)

Submissions should reference the program name in the subject line of the email.  If you have any questions about the sponsor or the application process, please contact LSO@vanderbilt.edu.


2020 Pew Biomedical Scholars Program

Applications due May 9

VUMC: These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Overview:

VUMC may nominate one candidate for the Pew Charitable Trusts' 2020 Pew Biomedical Scholars Award. The award supports Assistant Professors of outstanding promise in science relevant to human health. The award provides $300,000 in flexible support—$75,000 per year for a four-year period. Not more than 8 percent of the total award may be allocated for overhead costs.

Strong proposals will incorporate particularly creative and pioneering approaches. Candidates whose work is based on biomedical principles, but brings in concepts and theories from more diverse fields, are encouraged to apply.  Risk-taking is encouraged. Successful applications should not look like typical R01 grant applications with incremental research steps and safe hypotheses supported by existing data.

Selection of candidates will be based on a detailed description of the work that the applicant proposes to undertake, evaluations of the candidate’s performance, and notable past accomplishments, including honors, awards, and publications. The Committee gives considerable weight to evidence that the candidate is a successful independent investigator and has published significant work.

This program is distinct from the Pew-Stewart Scholars Program, but candidates may apply to both.

Eligibility:

  • Must have doctorate in biomedical sciences, medicine or a related field
  • As of Oct. 10, 2019, must hold full-time appointments at the rank of Assistant Professor. (Associate Professors are not eligible. Appointments such as Research Assistant Professor, Adjunct Assistant Professor, Assistant Professor Research Track, Visiting Professor or Instructor are not eligible.)
  • On June 14, 2019, must have been in such an appointment for less than three years (not appointed before June 14, 2016), whether or not such an appointment was on a tenure track.
    • Time spent in clinical internships, residencies, in work toward board certification, or on parental leave does not count as part of this three-year limit. Candidates who took parental leave should indicate this in their internal application.
  • The selected candidate may be nominated by VUMC two times in total. If previously applied through VUMC, may not reapply in a subsequent year from VU (and vice versa.)

Scope of Research:

  • Public health projects and those that are solely clinical research are not within the scope of Pew-funded research
  • Candidates conducting original basic and/or translational research related to the biomedical sciences are encouraged to apply
    • This includes “traditional” fields like genetics, immunology, neuroscience, cancer biology etc. However, candidates from areas such as computational science, chemistry, engineering, and physics are also strongly encouraged to apply
    • For examples of Pew scholar projects, a directory of past scholars can be found here, including previous Vanderbilt awardees (John Karijolich ’18, Lauren Parker Jackson ‘16; Ethan Lee ‘04; David Cortez ‘03).

Internal Application Process:

Anyone interested in being considered as Vanderbilt’s nominee must submit the following (in PDF format) to LSO@vanderbilt.edu  by 5 p.m. on May 9, 2019: 

  1. Brief research plan including summary budget (2 page max);
  2. Statement of support from department chair/center director;
  3. NIH Biosketch or abbreviated CV (5 page max)

Submissions should reference "PEW BIOMEDICAL SCHOLARS" in the subject line of the email. 

Following the internal review, the nominee’s name will be submitted to the Pew Charitable Trusts by June 14, 2019 and complete application will be due Oct. 17, 2019.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


2020 Pew-Stewart Scholars for Cancer Research Program

Applications due May 31

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

 

Overview:

 

Vanderbilt-Ingram Cancer Center may nominate one candidate for the Pew Charitable Trusts' 2020 Pew-Stewart Scholars for Cancer Research Program. This program supports Assistant Professors of outstanding promise in science relevant to the advancement of a cure for cancer. The award provides $300,000 in flexible support—$75,000 per year for a four-year period. Not more than 8 percent of the total award may be allocated for overhead costs.

 

Strong proposals will incorporate particularly creative and innovative approaches in cancer research. Candidates whose work is based on biomedical principles, but brings in concepts and theories from more diverse fields related to cancer, are encouraged to apply. Ideas with the potential to produce an unusually high impact are encouraged. Successful applications should not look like typical R01 grant applications with incremental research steps and safe hypotheses supported by existing data.

 

Selection of candidates will be based on a detailed description of the work that the applicant proposes to undertake, evaluations of the candidate’s performance, and notable past accomplishments, including honors, awards, and publications. The Committee gives considerable weight to evidence that the candidate is a successful independent investigator and has published significant work.

 

This program is distinct from the Pew Biomedical Scholars Program, but candidates may apply to both.

 

Eligibility Criteria:

  • Candidates must have been awarded a doctorate in a field related to biomedical sciences or medicine.
  • As of October 10, 2019, candidates must hold full-time appointments at the rank of Assistant Professor. (Associate Professors are not eligible. Appointments such as Research Assistant Professor, Adjunct Assistant Professor, Assistant Professor Research Track, Visiting Professor or Instructor are not eligible.)
  • On June 14, 2019, candidates must have been in such an appointment for less than three years (not appointed before June 14, 2016), whether or not such an appointment was on a tenure track.
    • Time spent in clinical internships, residencies, in work toward board certification, or on parental leave does not count as part of this three-year limit. Candidates who took parental leave should indicate this in their internal application.
  • Qualified candidates should be conducting creative, interdisciplinary, basic, or translational cancer research. Public health projects and those that are solely clinical research are not within the scope of Pew-funded research.
  • The selected candidate may be nominated by Vanderbilt two times in total. 
  • Funding from the NIH, other government sources, and project grants from non-profit associations do not pose a conflict.

Internal Application Process:

Anyone interested in being considered as Vanderbilt’s nominee must submit the following (in PDF format) to LSO@vanderbilt.edu  by 5 p.m. on May 9, 2019: 

  1. Brief research plan including summary budget (2 page max);
  2. Statement of support from department chair/center director;
  3. NIH Biosketch or abbreviated CV (5 page max)

Submissions should reference "PEW-STEWART SCHOLARS" in the subject line of the email. 

 

Following the internal review, the nominee’s name will be submitted to the Pew Charitable Trusts by June 14, 2019 and complete application will be due Oct. 10, 2019.

 

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


2019 Mallinckrodt Grant Program

Applications due May 9

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

 

Vanderbilt (VU and VUMC, collaboratively) may submit one proposal for the Edward Mallinckrodt Foundation Grant Program.  The Foundation supports early stage investigators engaged in basic biomedical research that has the potential to significantly advance the understanding, diagnosis, or treatment of disease.  The grant provides $60,000/year for up to a total of $180,000 over three years to move a project forward to the point where R01 or other independent funding can be obtained. Indirect costs are not allowable, but salary support is acceptable.  View the application guidelines for more information.

Eligibility Requirements (Must meet the following on August 1, 2019):

  • Hold M.D. and/or Ph.D. degree
  • In 1st to 4th year of a tenure-track position
  • Must not have current R01 funding

Internal Application Process:

Anyone interested in being considered as Vanderbilt’s potential nominee must submit the following (in PDF format) to LSO@vanderbilt.edu by 5:00 p.m. on May 31, 2019

  1. Brief research plan including summary budget (2 page maximum);
  2. Lay summary (1/2 page maximum);
  3. Letter of support from department chair/center director;
    1. Letter must acknowledge that this grant does not allow indirect costs.** This statement can be used/modified: “The Department recognizes that this grant does not allow indirect costs and will commit to covering any associated indirect costs per applicable institutional policy.”
  4. NIH Biosketch (5 page maximum)

**Process for cost-sharing typically coordinated at the departmental level and approved by department chair and/or dean. Please consult LSO@vanderbilt.edu for further guidance.

Submissions should reference the program name in the subject line of the email.  Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


 

 


Active Calls for NON-Limited External Opportunities 

Internal review process NOT required- Submit directly to Sponsor


Ovarian Cancer Research Alliance Grants & Investigator Awards (Multiple Award Types) 

Letters of Intent due April 28

Ovarian Cancer Research Alliance is the largest global charity funding ovarian cancer research. In the U.S., OCRA is the largest non-government funder of ovarian cancer research.  OCRA grant programs support postdoctoral fellows, early career independent investigators, and teams of experienced investigators.

 

Collaborative Research Development Grants ($900,000) provide funds for ovarian cancer research projects that involve several investigators within one institution or collaborations between groups in multiple institutions.

 

Liz Tilberis Early Career Awards ($450,000) are for investigators in their first academic faculty appointment.  This award is open to physician-scientists and Ph.D. scientists. 

 

Ann and Sol Schreiber Mentored Investigator Award ($75,000) funds post-doctoral trainees working in ovarian cancer research groups or those currently enrolled in a fellowship program. 

 

Letters of Intent are due April 28, 2019 and must be submitted via ProposalCENTRAL.  The attached application instructions are also available on the OCRAwebsite:  https://ocrahope.org/research/for-grantees/grant-application-faq/.  


Craig H. Neilsen Foundation Spinal Cord Injury Research on the Translational Spectrum

LOIs due May 4

The Spinal Cord Injury Research on the Translational Spectrum (SCIRTS) portfolio focuses on research designed to improve understanding and advance the current treatment of acute and chronic spinal cord injury. The goal of the portfolio is to address gaps in the field and advance novel approaches to improving function and developing curative therapies after spinal cord injury. The scope of this program is broad, encompassing mechanistic, preclinical modeling, translational and/or clinical research. 

POSTDOCTORAL FELLOWSHIPS

  • Two-year Postdoctoral Fellowships encourage early-career training and specialization in the field of spinal cord injury research.

PILOT RESEARCH GRANTS

  • Two-year Pilot Research Grants help to establish new investigators in the field of spinal cord injury research and support studies by established investigators who are undertaking new directions in their work. These grants cultivate new lines of research and generate essential preliminary data.

SENIOR RESEARCH GRANTS

  • Three-year Senior Research Grants encourage senior-level investigators to expand the scope of their work in targeted studies that will move the field along the translational spectrum. These grants are intended to open new areas of research, fill gaps in the spinal cord injury field and encourage cutting-edge ideas and approaches that have great potential, despite some additional uncertainty.

NIH Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)

Applications due May 1

Note: Only grantees previously funded under RFA-OD-14-003 are eligible to apply.

This RFA invites applications for the continued support and advancement of the Mutant Mouse Resource and Research Centers (MMRRC). The MMRRC consortium is expected to facilitate research by identifying, acquiring, evaluating, characterizing, cryopreserving, and distributing mutant mouse strains to qualified biomedical investigators. A regional network of four MMRRCs and an Informatics, Coordination and Service Center (ICSC) collectively serve the needs of the biomedical research community for transgenic, knockout and other genetically-engineered mutant mice and related biomaterials. MMRRC strains are held to the highest standards to optimize reproducibility of studies and assure scientific rigor and transparency; all submitted strains are thoroughly reviewed and documented and include additional quality control measures. The Program Director/Principal Investigator (PD/PI) of each MMRRC in addition to the major resource activities is required to develop a small high risk, high return, research pilot project that complements the goals and needs of the MMRRC consortium.  


DoD Autism Research Program (Multiple Award Types)

Pre-Applications due May 1

Clinical Trial Award

Note: nested early-career investigator option has different award criteria as indicated.

Eligibility

  • Investigators at or above the level of Associate Professor (or equivalent) 
  • Nested Early-Career Investigator Option: Investigators at or above the level of Associate Professor (or equivalent) may collaborate on a single application with a young investigator (at the level of postdoctoral fellow up to early-career independent faculty) who meets the following criteria at the application submission deadline date:
    • Must be in a current postdoctoral training position or have completed postdoctoral training by the application deadline
    • Is no more than 7 years from the receipt of a terminal degree

    • Has the freedom to commit at least 50% time to the project

Key Mechanism Elements

  • Supports research with the potential to have a major impact on the treatment and/or management of ASD.
  • Preliminary data relevant to the proposed clinical trial are required.
  • Pre-application is required; application submission is by invitation only.
  • Nested Early-Career Investigator Option: Supports the development of young investigators pursuing or wishing to pursue a career in ASD clinical trial research.

Funding

  • Maximum funding of $1,000,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 4 years
  • Nested Early-Career Investigator Option: Maximum funding of $1,155,000 for direct costs (plus indirect costs); Maximum period of performance is 4 years.

Clinical Translational Research Award

  • Investigators at or above the level of Assistant Professor (or equivalent)
  • Supports early-phase, proof-of-principle clinical trials with the potential to have a major impact on the treatment and/or management of ASD.
  • Preliminary data relevant to the proposed project are required.
  • Pre-application is required; application submission is by invitation only.
  • Maximum funding of $500,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 3 years

Idea Development Award

  • Investigators at or above the level of Assistant Professor (or equivalent), or
  • Multiple PI Option: 
  • Up to two investigators may collaborate on a single application, each of whom will be recognized as a Principal Investigator and receive a separate award. 
  • Supports the development of innovative, high-impact ideas that advance the understanding of ASD and ultimately lead to improved outcomes.  Preliminary data relevant to the proposed project are required.
  • Pre-application is required; application submission is by invitation only.
  • Clinical trials or applications including a clinical trial aim are not allowed.
  • Maximum funding of $500,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 3 years

Methods Development for Cryogenic or Other Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R21 Clinical Trial Not Allowed)

Applications due May 25

This program supports exploratory research projects aimed at developing cryogenic or other long-term preservation and revival approaches for Drosophila or zebrafish genetic stocks, which are essential laboratory animal models for biomedical research. The proposed project should address critical knowledge and technology gaps and describe approaches towards the development of reliable, easy-to-use and cost effective cryogenic or other long-term preservation and revival methods for wild-type and mutant strains of Drosophila or zebrafish.


Doris Duke Charitable Foundation 2019 Physician Scientist Award

Applications due June 7

Interested applicants are encouraged to contact Jenny Alexander (VUMCDEV Corporate & Foundation Relations) for assistance with proposal development.

The Doris Duke Physician Scientist Fellowship program provides grants to physician scientists at the subspecialty fellowship level who are seeking to conduct additional years of research beyond their subspecialty requirement. The goal is to aid in the transition into a research faculty appointment.

The Physician Scientist Fellowship consists of $100,000 for annual direct costs plus $10,000 (10 percent) for annual indirect costs for one or two years, depending on the need of the applicant. The priority of the Physician Scientist Fellowship program is to fund outstanding individuals with excitement for clinical research careers, whose projects will address highly significant research questions and lead to career advancement. DDCF does not have funding priorities for this fellowship based on disease area or research type.

In keeping with the wishes expressed in Doris Duke's will, experiments that use animals or primary tissues derived from animals will not be supported by this program.


HESI THRIVE Grant – Making Cancer Patient Quality of Life an Active Research Priority

Letters of Intent Due July 1

THRIVE, a partner in the 2018 Biden Cancer Initiative, provides seed grants for nonclinical, clinical, and translational research and technology-based solutions that enhance our ability to predict when and how adverse effects may occur in patients who have received cancer treatment. THRIVE also supports the development of approaches to avoid or lessen these effects. 

The THRIVE grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting of preliminary data to help secure long-term funding by the National Institutes of Health and/or other major granting institutions.

Most awards will be within the range of $20,000 - $50,000 over 24 months. Upon agreement to THRIVE award terms, THRIVE will disburse 75% of funds with the remaining provided upon completion of the study milestones


Alkermes Pathways Awards for Research on Substance Use Disorders or Schizophrenia

Applications due July 31

With millions of people impacted by central nervous system disorders, more research is urgently needed to bring relief to those who are suffering. The ALKERMES PATHWAYS RESEARCH AWARDS program furthers our commitment to serving the needs of patients and is designed to support the next generation of researchers who are working on the front-lines to advance our understanding and awareness of central nervous system disorders.

In its second year (2019), the ALKERMES PATHWAYS RESEARCH AWARDS program will support projects focused on substance use disorders (SUDs) and schizophrenia.

Open to early career investigators committed to advancing research in SUDs and schizophrenia, the annual Pathways program provides funding for up to 8 research projects with an individual grant amount of up to $100,000 per project. Alkermes has reserved 4 awards for the SUDs program and 4 for the schizophrenia program.

This grant is for investigators who are in the early stages of their career; specifically, they may be the recipient of a career development (K) award or other mentored research grant, but not a funded R01 grant or equivalent at the time of application. Researchers with an academic position above assistant professor are not eligible.


Canada's 2019-2020 Banting Postdoctoral Fellowships Competition

Applications due September 18

The Banting Postdoctoral Fellowship is Canada’s most prestigious and highest valued award for postdoctoral researchers today. The Banting Postdoctoral Fellowships program is designed to support world-class postdoctoral researchers. The fellowship provides $70,000 per year for two years. The program is open to both Canadian and international researchers who have recently completed a PhD, PhD- equivalent, or health professional degree. Applications must be completed in full collaboration with the proposed host institution. 


NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)

Applications due September 21

This program supports collaborative investigative teams or individual scientists who propose unusually innovative research projects, which, if successful, would have a major impact in a broad area of relevance to the NIH.

To be considered transformative, projects must have the potential to create or overturn fundamental scientific paradigms through novel approaches, transform the way research is conducted through the development of novel tools or technologies, or lead to major improvements in health through the development of highly innovative therapies, diagnostic tools, or preventive strategies. Consistent with this focus, Transformative Research Award applications should reflect ideas substantially different from mainstream concepts.